Untitled - EAS

Florian Kronenberg

Professor

Contributions

2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidemias – Advancing evidence-based care through innovationCommentariesPublication The essential role of sex and gender in atherosclerosis research: A statement from the Editorial Board of Atherosclerosis and Executive Committee of the European Atherosclerosis SocietyCommentariesPublication Lp(a) - who to measure and what to do about it?Lp(a) Awareness Day92nd EAS Congress 2024NLA-EAS Joint Session Importance of Measuring Lp(a) in patients with HeFH & HoFHLp(a) Awareness DayRare Disease DayHoFH Awareness DayWebinars on-demandJoint FH Webinar series 2023: Let’s manage FH together Panel Discussion: From evidence to action with elevated Lp(a)_ perspectives on clinical implications and testing91st EAS Congress 2023From evidence to action with elevated Lp(a)_ perspectives on clinical implications and testing What do we need to do? A call to action on Lp(a) testingLp(a) Awareness Day91st EAS Congress 2023From evidence to action with elevated Lp(a)_ perspectives on clinical implications and testing Lp(a) - Finding the right placeLp(a) Awareness DayIntegrating the many players of cardiovascular risk91st EAS Congress 2023 LCN Lp(a) webinar series #2: Why and how to measure Lp(a)Lp(a) Awareness DayWebinars on-demand EAS Advanced Course in Rare Lipid Disorders - from ViennaWebinars on-demand Industry Special Lecture - Discussion and Q&A90th EAS Congress 2022Industry Special Lecture Why measure Lp(a) and how do I interpret it?90th EAS Congress 2022Industry Special Lecture Lipoprotein(a) - on the way to a consensus90th EAS Congress 2022EAS Consensus activities(ReviewMetab lipoLipidologyLp(a))Aortic valve calcification: The role of lipoprotein (a)89th EAS Congress 2021(AtherothrombosisLipidologyLipid risk factorsLp(a))